Literature DB >> 9467369

Oral diseases, mycology and periodontal microbiology of HIV-1-infected women.

L J Brady1, C Walker, G E Oxford, C Stewart, I Magnusson, W McArthur.   

Abstract

HIV-1 infection is increasing more rapidly among heterosexual women. Relatively limited information is available on HIV-related oral pathoses in these individuals. To gain insight into the type and occurrence of oral lesions in this population, 25 HIV-1 infected women including asymptomatic, symptomatic and AIDS patients were examined clinically and sampled for detection of oral yeast and characterization of their subgingival microbial flora. Sixty percent of the subjects were African-American, with 80% infected via heterosexual contact. Oral candidiasis was the most common nonperiodontal oral lesion, observed in 44% of the patients. Oral yeast was cultured from all women with candidiasis and 76% of the total subjects. Oral hairy leukoplakia was clinically diagnosed in 16% of the subjects. Clinically mild to moderate gingivitis and periodontitis were observed in 84% and 52% of the patients, respectively. Candidiasis and the presence of cultivable yeast were observed in patients with low, intermediate, and high CD4+ T lymphocyte numbers. Plaque samples were collected from each subject and enumerated by predominant cultivable methods, selective media and microscopy. No differences were detected in the microflora associated with seropositive women with existing periodontitis relative to those without periodontitis or to seronegative women with periodontitis. Candidiasis was the most notable oral clinical manifestation in the HIV-1-infected women and may be a useful clinical indicator of early immune dysfunction mediated by HIV-1.

Entities:  

Mesh:

Year:  1996        PMID: 9467369     DOI: 10.1111/j.1399-302x.1996.tb00198.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  8 in total

Review 1.  Oral innate immunity in HIV infection in HAART era.

Authors:  Wipawee Nittayananta; Renchuan Tao; Lanlan Jiang; Yuanyuan Peng; Yuxiao Huang
Journal:  J Oral Pathol Med       Date:  2015-01-31       Impact factor: 4.253

2.  Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions.

Authors:  M A Jabra-Rizk; S M Ferreira; M Sabet; W A Falkler; W G Merz; T F Meiller
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

3.  Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro, Brazil.

Authors:  M B Portela; I P R Souza; E M M B Costa; A N Hagler; R M A Soares; A L S Santos
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

4.  A Comparison of Chronic Periodontitis in HIV-Seropositive Subjects and the General Population in the Ga-Rankuwa Area, South Africa.

Authors:  Razia Khammissa; Liviu Feller; Mario Altini; Paul Fatti; Johan Lemmer
Journal:  AIDS Res Treat       Date:  2012-08-29

5.  Estimation of prevalence of periodontal disease and oral lesions and their relation to CD4 counts in HIV seropositive patients on antiretroviral therapy regimen reporting at District General Hospital, Raichur.

Authors:  Jagganatha Rao Ravi; Tuthipat Ramachandra Gururaja Rao
Journal:  J Indian Soc Periodontol       Date:  2015 Jul-Aug

Review 6.  Applications of the FIV Model to Study HIV Pathogenesis.

Authors:  Craig Miller; Zaid Abdo; Aaron Ericsson; John Elder; Sue VandeWoude
Journal:  Viruses       Date:  2018-04-20       Impact factor: 5.048

7.  Pathogenesis of oral FIV infection.

Authors:  Craig Miller; Karen Boegler; Scott Carver; Martha MacMillan; Helle Bielefeldt-Ohmann; Sue VandeWoude
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

8.  BANA-Positive Plaque Samples Are Associated with Oral Hygiene Practices and Not CD4+ T Cell Counts in HIV-Positive Patients.

Authors:  Cathy Nisha John; Lawrence Xavier Graham Stephen; Charlene Wilma Joyce Africa
Journal:  Int J Dent       Date:  2012-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.